New study aims to catch diabetic eye disease earlier with advanced testing

NCT ID NCT06821399

Recruiting now Diagnosis Sponsor: Yufan Wang Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will enroll nearly 3,000 people with type 2 diabetes to improve how diabetic retinopathy (an eye disease) is diagnosed and managed. Researchers will use eye exams, blood tests, and continuous glucose monitors to build better models for predicting and treating the condition. The goal is to create personalized care plans that slow or prevent vision loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better early warning systems and personalized treatment plans for diabetic retinopathy, potentially preventing vision loss.
What could go wrong: This is an observational study, so it won't test a new treatment. The results may not apply to all patients, and the models need further validation before use in clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic retinopathy type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DIABETIC RETINOPATHY TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Locations

Shanghai general hosptial
RECRUITING

Shanghai, China
The first hosptial of lanzhou university
RECRUITING

Lanzhou, China
The forth people's hosptial of shenyang
RECRUITING

Shenyang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.